139 related articles for article (PubMed ID: 2543500)
21. Postirradiation glucan administration enhances the radioprotective effects of WR-2721.
Patchen ML; MacVittie TJ; Jackson WE
Radiat Res; 1989 Jan; 117(1):59-69. PubMed ID: 2536480
[TBL] [Abstract][Full Text] [Related]
22. Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow cultures.
Kubo Y; Sieber F
Bone Marrow Transplant; 1997 Jul; 20(1):27-31. PubMed ID: 9232252
[TBL] [Abstract][Full Text] [Related]
23. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
24. Eradication of small cell lung cancer cells from human bone marrow with immunotoxins.
Myklebust AT; Godal A; Pharo A; Juell S; Fodstad O
Cancer Res; 1993 Aug; 53(16):3784-8. PubMed ID: 8393381
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
Gallicchio VS; Casale GP; Watts T
Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
[TBL] [Abstract][Full Text] [Related]
26. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
27. The protection of hemopoietic mice progenitors by WR-2721 during photodynamic therapy.
Maloisel F; Foultier MT; Patrice T; Praloran V; Oberling F; Le Bodic L
Nouv Rev Fr Hematol (1978); 1990; 32(5):357-9. PubMed ID: 1965991
[TBL] [Abstract][Full Text] [Related]
28. Effects of low dose rate irradiation on human marrow hematopoietic and microenvironmental cells: sparing effect upon survival of stromal and leukemic cells.
Laver J; Kwon JH; Castro-Malaspina H
Bone Marrow Transplant; 1987 Oct; 2(3):271-8. PubMed ID: 3332175
[TBL] [Abstract][Full Text] [Related]
29. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
Skala JP; Rogers PC; Chan KW; Rodriguez WC
Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
[No Abstract] [Full Text] [Related]
30. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
31. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
32. Dye-mediated photosensitization of murine neuroblastoma cells.
Sieber F; Sieber-Blum M
Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
[TBL] [Abstract][Full Text] [Related]
33. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
34. Normal blast colony formation: an in vitro tool for monitoring human bone marrow 'purging'.
Degliantoni G; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1986 Dec; 1(2):209-13. PubMed ID: 3332133
[TBL] [Abstract][Full Text] [Related]
35. In vitro hematopoiesis following induction chemotherapy for acute leukemia.
Beyer GS; Bruno E; Hoffman R
Cancer Res; 1985 Nov; 45(11 Pt 2):5921-5. PubMed ID: 4053063
[TBL] [Abstract][Full Text] [Related]
36. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
37. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
38. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
39. Suppression of normal human hematopoiesis by cytomegalovirus in vitro.
MacKintosh FR; Adlish J; Hall SW; St Jeor S; Smith E; Tavassoli M; Zanjani ED
Exp Hematol; 1993 Feb; 21(2):243-50. PubMed ID: 8381087
[TBL] [Abstract][Full Text] [Related]
40. Inducing effects of macrophage stimulating protein on the expansion of early hematopoietic progenitor cells in liquid culture.
Ma LX; Huang YH; Cheng LM; Lei J; Wang QR
Chin Med J (Engl); 2007 Jul; 120(13):1192-7. PubMed ID: 17637252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
